A groundbreaking advancement in ophthalmology has been achieved as Super Vision Technology announced that its i-NYS (Extraocular Neuromuscular Stimulator Implant), the world’s first implantable ...
With the singular exception of punctal or canalicular occlusion, when we are talking about in-office dry eye disease ...
If you’ve noticed the world looking dimmer, colors losing their spark, or headlights becoming blinding at night, you’re not alone, and you don’t have to just ‘live with it.’ If you, or someone you ...
NASHVILLE, Tenn.--(BUSINESS WIRE)--Sanaregen Vision Therapeutics, a clinical-stage regenerative medicine company, today announced clearance by the U.S. Food and Drug Administration to conduct a Phase ...
Sanaregen Vision Therapeutics, a clinical-stage regenerative medicine company, today announced clearance by the U.S. Food and Drug Administration to conduct a Phase I/II clinical trial for SVT-001, ...
We believe SVT-001 provides true hope to prevent the almost inevitable vision loss caused by this devastating condition that has largely been overlooked.” — Anthony Oliva, Ph.D., Chief Scientific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results